BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8051398)

  • 1. Activation of T cells by previously activated T cells. HLA-unrestricted alternative pathway that modifies their proliferative potential.
    Bouchonnet F; Lecossier D; Bellocq A; Hamy I; Hance AJ
    J Immunol; 1994 Sep; 153(5):1921-35. PubMed ID: 8051398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting cells for naive transgenic gamma delta T cells. Potent activation by activated alpha beta T cells.
    Spaner D; Cohen BL; Miller RG; Phillips RA
    J Immunol; 1995 Oct; 155(8):3866-76. PubMed ID: 7561093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis.
    Balaji KN; Schwander SK; Rich EA; Boom WH
    J Immunol; 1995 Jun; 154(11):5959-68. PubMed ID: 7751639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals.
    Subauste CS; Fuh F; de Waal Malefyt R; Remington JS
    J Immunol; 1998 Apr; 160(7):3403-11. PubMed ID: 9531300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
    Pietra BA; De Inocencio J; Giannini EH; Hirsch R
    J Immunol; 1994 Aug; 153(4):1881-8. PubMed ID: 7913945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique phenotype and distinct TCR V beta repertoire in human peripheral blood alpha beta TCR+, CD4-, and CD8- double negative T cells.
    Niehues T; Gulwani-Akolkar B; Akolkar PN; Tax W; Silver J
    J Immunol; 1994 Feb; 152(3):1072-81. PubMed ID: 8301117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of naive and memory phenotypes on resting CD4 T cells in vivo.
    Boursalian TE; Bottomly K
    J Immunol; 1999 Jan; 162(1):9-16. PubMed ID: 9886364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.
    Waldrop SL; Davis KA; Maino VC; Picker LJ
    J Immunol; 1998 Nov; 161(10):5284-95. PubMed ID: 9820501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
    Arase-Fukushi N; Arase H; Ogasawara K; Good RA; OnoƩ K
    J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.
    Wu CY; Demeure C; Kiniwa M; Gately M; Delespesse G
    J Immunol; 1993 Aug; 151(4):1938-49. PubMed ID: 8102154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins.
    Hawes GE; Struyk L; van den Elsen PJ
    J Immunol; 1993 Mar; 150(5):2033-45. PubMed ID: 8436833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.
    Gudmundsdottir H; Wells AD; Turka LA
    J Immunol; 1999 May; 162(9):5212-23. PubMed ID: 10227995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.